Drug Designing and Biomarkers
Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three-dimensional structure and computational techniques are known as structure-based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure-based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogs. Biomarkers include tools and technologies that aid in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease
Related Conference of Drug Designing and Biomarkers
Drug Designing and Biomarkers Conference Speakers
Recommended Sessions
- Advances in Structural and Molecular Biology
- BIOINFORMATICS
- BLOTTING TECHNIQUES
- Computational Approaches in Structural Biology
- DNA & RNA
- DNA fingerprinting
- Drug Designing and Biomarkers
- GENE BANKS
- Genomics
- Hybrid Approaches for Structure Prediction
- PCR
- Proteomics
- Signaling Biology
- Structural Biology and the Evolution of Bio macromolecules
- Structural Biology in Cancer Therapeutics
- VECTORS
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)